Evidence map›Paper›PMID 39132095›Full record

ReviewTherapeutic advances in infectious disease

Acute drug-use-related native tricuspid valve infective endocarditis: a non-surgical disease.

Sami El-Dalati, Talal Alnabelsi, John Gurley, Kelli Cremeans, Hassan Reda, Tessa London-Bounds, Erinn Ogburn, Michael Sekela

Abstract readReview
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sami El-DalatiDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky Medical Center, 3101 Beaumont Centre Circle, Lexington, KY 40513, USA.ORCID https://orcid.org/0000-0003-2603-2951
Talal AlnabelsiGill Heart and Vascular Institute, University of Kentucky Medical Center, Lexington, KY, USA.
John GurleyGill Heart and Vascular Institute, University of Kentucky Medical Center, Lexington, KY, USA.
Kelli CremeansDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky Medical Center, Lexington, KY, USA.
Hassan RedaDivision of Cardiovascular and Thoracic Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
Tessa London-BoundsDivision of Cardiovascular and Thoracic Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
Erinn OgburnDivision of Cardiovascular and Thoracic Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
Michael SekelaDivision of Cardiovascular and Thoracic Surgery, University of Kentucky Medical Center, Lexington, KY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a result of the ongoing opioid epidemic, physicians have encountered increasing rates of drug-use-related native tricuspid valve infective endocarditis (DU-TVIE), a complex multi-faceted disease that is best managed by interdisciplinary teams. Despite the large number of patients with DU-TVIE, there is little data to support the optimal treatment strategy with respect to medical and surgical therapy. The recent introduction of percutaneous mechanical aspiration of tricuspid valve vegetations has added another treatment modality that is also of uncertain benefit. Here we review the literature on the management of DU-TVIE and highlight the multi-step treatment approach developed by the multidisciplinary endocarditis team at the University of Kentucky.

Indexed as

endocarditismultidisciplinary teamssubstance use disordertricuspid valve disease

Identifiers

PMID39132095
PMCPMC11311191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.